Emgality® (Galcanezumab)

Para consultar la información para prescribir completa de Emgality® (Galcanezumab) de clic en el siguiente enlace: Información para prescribir

La información es proporcionada en respuesta a su solicitud, y puede contener datos relacionados a dosis, usos, formulaciones y poblaciones diferentes a la Información para Prescribir del producto. Consulte la Información para Prescribir en la liga que aparece arriba.

Galcanezumab: Aseptic Techniques During Supply Shortages

During medical supply shortages, Lilly encourages patients to contact their health care provider for assistance.

MX_cFAQ_GLC014_ASEPTIC_SHORTAGES
MX_cFAQ_GLC014_ASEPTIC_SHORTAGES
es-MX

Injection Aseptic Techniques

Patients should follow the guidance on good aseptic techniques, such as handwashing and use of alcohol swabs, as outlined in the galcanezumab “Instructions for Use.”1

Guidance During Medical Supply Shortages

The COVID-19 pandemic has caused widespread medical supply shortages, including alcohol swabs and bottles of 70% isopropyl alcohol.

During shortages, patients should contact their health care provider for suggested alternative aseptic measures.

Injection Site Preparation

As an alternative to the use of alcohol, the WHO recommends the use of soap and water for skin preparation and disinfection of injection sites.2

References

1Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2World Health Organization. WHO best practices for injections and related procedures toolkit. Published March 2010. Accessed March 23, 2020. https://apps.who.int/iris/bitstream/handle/10665/44298/9789241599252_eng.pdf?sequence=1

Glossary

COVID-19 = coronavirus disease 2019

Lilly = Eli Lilly and Company

WHO = World Health Organization

Fecha de la última revisión: 2020 M03 27


Contáctenos para saber más de la información Médica de Lilly

Contacto vía correo electrónico

Correo electrónico: infomed@lilly.com

Envíe su consulta

Escriba su consulta